Copyright Reports & Markets. All rights reserved.

Global Biological API Drug Manufacturing Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    Global Biological API Drug Manufacturing Market Insights, Forecast to 2025

      1 Study Coverage

      • 1.1 Biological API Drug Manufacturing Product Introduction
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Type
        • 1.4.2 In-House manufacturing
        • 1.4.3 Contract manufacturing
      • 1.5 Market by Application
        • 1.5.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Application
        • 1.5.2 Monoclonal Antibody (mAb) Therapies
        • 1.5.3 Vaccines
        • 1.5.4 Insulin Therapies
        • 1.5.5 Interferon Therapies
        • 1.5.6 Other
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Biological API Drug Manufacturing Production
        • 2.1.1 Global Biological API Drug Manufacturing Revenue 2014-2025
        • 2.1.2 Global Biological API Drug Manufacturing Production 2014-2025
        • 2.1.3 Global Biological API Drug Manufacturing Capacity 2014-2025
        • 2.1.4 Global Biological API Drug Manufacturing Marketing Pricing and Trends
      • 2.2 Biological API Drug Manufacturing Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Biological API Drug Manufacturing Manufacturers
          • 2.3.2.1 Biological API Drug Manufacturing Manufacturing Base Distribution, Headquarters
          • 2.3.2.2 Manufacturers Biological API Drug Manufacturing Product Offered
          • 2.3.2.3 Date of Manufacturers Enter into Biological API Drug Manufacturing Market
      • 2.4 Market Drivers, Trends and Issues

      3 Market Size by Manufacturers

      • 3.1 Biological API Drug Manufacturing Production by Manufacturers
        • 3.1.1 Biological API Drug Manufacturing Production by Manufacturers
        • 3.1.2 Biological API Drug Manufacturing Production Market Share by Manufacturers
        • 3.1.3 Global Market Concentration Ratio (CR5 and HHI)
      • 3.2 Biological API Drug Manufacturing Revenue by Manufacturers
        • 3.2.1 Biological API Drug Manufacturing Revenue by Manufacturers (2014-2019)
        • 3.2.2 Biological API Drug Manufacturing Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Biological API Drug Manufacturing Market Concentration Ratio (CR10 and HHI)
      • 3.3 Biological API Drug Manufacturing Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Biological API Drug Manufacturing Production by Regions

      • 4.1 Global Biological API Drug Manufacturing Production by Regions
        • 4.1.1 Global Biological API Drug Manufacturing Production Market Share by Regions
        • 4.1.2 Global Biological API Drug Manufacturing Revenue Market Share by Regions
      • 4.2 North America
        • 4.2.1 North America Biological API Drug Manufacturing Production
        • 4.2.2 North America Biological API Drug Manufacturing Revenue
        • 4.2.3 Key Players in North America
        • 4.2.4 North America Biological API Drug Manufacturing Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Biological API Drug Manufacturing Production
        • 4.3.2 Europe Biological API Drug Manufacturing Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Biological API Drug Manufacturing Import & Export
      • 4.4 China
        • 4.4.1 China Biological API Drug Manufacturing Production
        • 4.4.2 China Biological API Drug Manufacturing Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Biological API Drug Manufacturing Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Biological API Drug Manufacturing Production
        • 4.5.2 Japan Biological API Drug Manufacturing Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Biological API Drug Manufacturing Import & Export

      5 Biological API Drug Manufacturing Consumption by Regions

      • 5.1 Global Biological API Drug Manufacturing Consumption by Regions
        • 5.1.1 Global Biological API Drug Manufacturing Consumption by Regions
        • 5.1.2 Global Biological API Drug Manufacturing Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Biological API Drug Manufacturing Consumption by Application
        • 5.2.2 North America Biological API Drug Manufacturing Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Biological API Drug Manufacturing Consumption by Application
        • 5.3.2 Europe Biological API Drug Manufacturing Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Biological API Drug Manufacturing Consumption by Application
        • 5.4.2 Asia Pacific Biological API Drug Manufacturing Consumption by Regions
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Biological API Drug Manufacturing Consumption by Application
        • 5.5.2 Central & South America Biological API Drug Manufacturing Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Biological API Drug Manufacturing Consumption by Application
        • 5.6.2 Middle East and Africa Biological API Drug Manufacturing Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Biological API Drug Manufacturing Breakdown Dada by Type
      • 6.2 Global Biological API Drug Manufacturing Revenue by Type
      • 6.3 Biological API Drug Manufacturing Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Biological API Drug Manufacturing Breakdown Dada by Application
        • 7.2.1 Global Biological API Drug Manufacturing Consumption by Application
        • 7.2.2 Global Biological API Drug Manufacturing Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Lonza
        • 8.1.1 Lonza Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.1.4 Biological API Drug Manufacturing Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Boehringer Ingelheim BioXcellence
        • 8.2.1 Boehringer Ingelheim BioXcellence Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.2.4 Biological API Drug Manufacturing Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Celltrion
        • 8.3.1 Celltrion Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.3.4 Biological API Drug Manufacturing Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 DSM
        • 8.4.1 DSM Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.4.4 Biological API Drug Manufacturing Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Samsung BioLogics
        • 8.5.1 Samsung BioLogics Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.5.4 Biological API Drug Manufacturing Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Fujifilm Diosynth Biotechnologies
        • 8.6.1 Fujifilm Diosynth Biotechnologies Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.6.4 Biological API Drug Manufacturing Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Cytovance Biologics
        • 8.7.1 Cytovance Biologics Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.7.4 Biological API Drug Manufacturing Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 AbbVie
        • 8.8.1 AbbVie Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.8.4 Biological API Drug Manufacturing Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Baxter
        • 8.9.1 Baxter Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.9.4 Biological API Drug Manufacturing Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 CEPiA Sanofi
        • 8.10.1 CEPiA Sanofi Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Biological API Drug Manufacturing
        • 8.10.4 Biological API Drug Manufacturing Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 GSK
      • 8.12 Pfizer CentreOne
      • 8.13 Sandoz
      • 8.14 Vetter
      • 8.15 Wuxi Biologics

      9 Production Forecasts

      • 9.1 Biological API Drug Manufacturing Production and Revenue Forecast
        • 9.1.1 Global Biological API Drug Manufacturing Production Forecast 2019-2025
        • 9.1.2 Global Biological API Drug Manufacturing Revenue Forecast 2019-2025
      • 9.2 Biological API Drug Manufacturing Production and Revenue Forecast by Regions
        • 9.2.1 Global Biological API Drug Manufacturing Revenue Forecast by Regions
        • 9.2.2 Global Biological API Drug Manufacturing Production Forecast by Regions
      • 9.3 Biological API Drug Manufacturing Key Producers Forecast
        • 9.3.1 North America
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Biological API Drug Manufacturing Production Forecast by Type
        • 9.4.2 Global Biological API Drug Manufacturing Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Biological API Drug Manufacturing Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Biological API Drug Manufacturing Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Biological API Drug Manufacturing Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Biological API Drug Manufacturing Consumption Forecast by Regions 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 South Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Biological API Drug Manufacturing Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Biological API Drug Manufacturing Consumption Forecast by Countries 2019-2025
        • 10.7.2 Turkey
        • 10.7.3 GCC Countries
        • 10.7.4 Egypt
        • 10.7.5 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Biological API Drug Manufacturing Upstream Market
        • 11.1.1 Biological API Drug Manufacturing Key Raw Material
        • 11.1.2 Typical Suppliers of Key Biological API Drug Manufacturing Raw Material
        • 11.1.3 Biological API Drug Manufacturing Raw Material Market Concentration Rate
      • 11.2 Biological API Drug Manufacturing Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Biological API Drug Manufacturing Distributors
      • 11.5 Biological API Drug Manufacturing Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details

        This report researches the worldwide Biological API Drug Manufacturing market size (value, capacity, production and consumption) in key regions like North America, Europe, China and Japan.
        This study categorizes the global Biological API Drug Manufacturing breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Lonza
        Boehringer Ingelheim BioXcellence
        Celltrion
        DSM
        Samsung BioLogics
        Fujifilm Diosynth Biotechnologies
        Cytovance Biologics
        AbbVie
        Baxter
        CEPiA Sanofi
        GSK
        Pfizer CentreOne
        Sandoz
        Vetter
        Wuxi Biologics

        Biological API Drug Manufacturing Breakdown Data by Type
        In-House manufacturing
        Contract manufacturing

        API contract manufacturing dominates the global biological API drug manufacturing market.

        Biological API Drug Manufacturing Breakdown Data by Application
        Monoclonal Antibody (mAb) Therapies
        Vaccines
        Insulin Therapies
        Interferon Therapies
        Other

        Biological API Drug Manufacturing Production Breakdown Data by Region
        North America
        Europe
        China
        Japan

        Biological API Drug Manufacturing Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
        Central & South America
        Brazil
        Middle East & Africa
        Turkey
        GCC Countries
        Egypt
        South Africa

        The study objectives are:
        To analyze and research the global Biological API Drug Manufacturing capacity, production, value, consumption, status and forecast;
        To focus on the key Biological API Drug Manufacturing manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Biological API Drug Manufacturing :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
        Buy now